sábado, 30 de mayo de 2026

The Potential for Remission, Cure in Psoriasis With Biologic Treatment: A Q&A With Andrew Blauvelt, MD, MBA Christine Kilgore May 27, 2026 ++++ ++++

The Potential for Remission, Cure in Psoriasis With Biologic Treatment: A Q&A With Andrew Blauvelt, MD, MBA Christine Kilgore https://www.medscape.com/viewarticle/potential-remission-cure-psoriasis-biologic-treatment-q-2026a1000hlg?ecd=mkm_ret_260530_mscpmrk_derm_biologics-in-derm_etid8382686&uac=148436CN&impID=8382686 May 27, 2026 Andrew Blauvelt, MD, MBA, began to study psoriasis in depth in Portland, Oregon, over 20 years ago, after spending several years at the National Institutes of Health training in cellular immunology and working as a senior investigator on HIV. In Portland, he was a professor at Oregon Health & Science University, where he conducted basic science research on the immunology of psoriasis, with a focus on how interleukin (IL)-23 and Th17 cells contribute to psoriasis pathogenesis. Biologics Continue to Transform Psoriasis Care, Giving Physicians and Patients More Options Damian McNamara, MA https://www.medscape.com/viewarticle/biologics-continue-transform-psoriasis-care-giving-2026a1000hs6?ecd=mkm_ret_260530_mscpmrk_derm_biologics-in-derm_etid8382686&uac=148436CN&impID=8382686 May 28, 2026 This is the second installment of a four-part series on biologics and dermatology, further exploring the impact of biologics in the treatment of dermatologic diseases. Future installments will focus on atopic dermatitis and other skin diseases. Exciting Developments in Psoriasis From AAD 2026 Shawn G. Kwatra, MD https://www.medscape.com/viewarticle/updates-psoriasis-and-related-disorders-aad-2026-2026a10008be?ecd=mkm_ret_260530_mscpmrk_derm_biologics-in-derm_etid8382686&uac=148436CN&impID=8382686 Clinical Impact of AAD 2026: Integrating Weight Management into Psoriasis Care Tina Bhutani, MD, MAS https://www.medscape.com/viewarticle/mdangle-aad-2026-psoriasis-clinical-impact-2026a10005ba?ecd=mkm_ret_260530_mscpmrk_derm_biologics-in-derm_etid8382686&uac=148436CN&impID=8382686 Expert Guidance on Switching, Stacking Systemic Therapies for Psoriasis Damian McNamara, MA https://www.medscape.com/viewarticle/expert-guidance-switching-stacking-systemic-therapies-2026a1000gyp?ecd=mkm_ret_260530_mscpmrk_derm_biologics-in-derm_etid8382686&uac=148436CN&impID=8382686 May 25, 2026 How Much Monitoring Is Enough in Psoriasis Care? Steven R. Feldman, MD, PhD; Jennifer C. Cather, MD; Brad P. Glick, DO, MPH, FAAD, FAOCD https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep3-2026a10006hk?ecd=mkm_ret_260530_mscpmrk_derm_biologics-in-derm_etid8382686&uac=148436CN&impID=8382686 Identifying Lesions on Skin of Color Carly A. Elston, MD; Dirk M. Elston, MD https://reference.medscape.com/p11/identifying-lesions-skin-color-2026a1000eg1?ecd=mkm_ret_260530_mscpmrk_derm_biologics-in-derm_etid8382686&uac=148436CN&impID=8382686 National Psoriasis Foundation Outlines Role of GLP-1 RAs for Psoriasis Ted Bosworth https://www.medscape.com/viewarticle/national-psoriasis-foundation-outlines-role-glp-1-ras-2026a1000ear?ecd=mkm_ret_260530_mscpmrk_derm_biologics-in-derm_etid8382686&uac=148436CN&impID=8382686

No hay comentarios:

Publicar un comentario